The FDA Grants Priority Review for Potential New Follicular Lymphoma Treatment, Epcoritamab, by Genmab A/S and AbbVie Genmab A/S (NASDAQ: GMAB) and AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for...
Tech Sector’s AI-Fueled Rally Shows Signs of Slowing as Interest Rate Concerns Loom Over U.S. Stock Futures Late Sunday trading saw minimal movement in U.S. stock futures following a period of record highs, signaling a potential slowdown in the tech...
Fresh Del Monte Produce experienced a challenging last quarter, reporting revenues of $1.00 billion, marking a 4.8% year-on-year decline and missing analyst expectations by 6.5%. This downturn reflected a slower period for the company, falling short of both revenue...
Fed’s Cook: Economy’s Risks Two-Sided, Caution on Rate Cuts U.S. Federal Reserve Governor Lisa Cook addressed on Thursday the evolving economic landscape, highlighting that as inflation shows signs of easing and the labor market adjusts, the risks facing...
Elevation Oncology, Inc. (NASDAQ:ELEV) has unveiled the extension of its Phase 1 clinical trial for EO-3021, a promising cancer therapy, marking the dosing of the inaugural patient in Japan. This expansion represents a strategic move in the company’s...
